Drug profile · INN
galsulfase
NAGLAZYME
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
galsulfase (NAGLAZYME) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN galsulfase
Brand NAGLAZYME
Route INJECTION
Formulation INJECTABLE
ATC code A16AB
Originator BioMarin International Limited
Frequently asked questions
What is galsulfase?
galsulfase (NAGLAZYME) is an FDA-listed pharmaceutical active ingredient. Associated with BioMarin International Limited. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for galsulfase?
NAGLAZYME is a marketed brand name for galsulfase. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of galsulfase?
galsulfase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.